Fortune Rise Acquisition Corporation

Fortune Rise Acquisition Corporation (Nasdaq: FRLA), relating to its proposed merger with Water On Demand, Inc. Under the terms of the agreement, all FRLA common stock will be converted into the right to receive shares of Water On Demand common stock.

Pieris Pharmaceuticals, Inc.

Pieris Pharmaceuticals, Inc. (Nasdaq: PIRS), relating to its proposed merger with Palvella Therapeutics, Inc. Under the terms of the agreement, Pieris shareholders are expected to own approximately 18% of the combined company.

Revance Therapeutics, Inc.

Revance Therapeutics, Inc. (Nasdaq: RVNC), relating to its proposed merger with Crown Laboratories, Inc. Under the terms of the agreement, Revance shareholders will receive $6.66 in cash per share they own.

GSE Systems, Inc.

GSE Systems, Inc. (Nasdaq: GVP), relating to its proposed merger with Pelican Energy Partners. Under the terms of the agreement, GSE Systems shareholders will receive $4.10 in cash per share they own.

G1 Therapeutics, Inc.

G1 Therapeutics, Inc. (Nasdaq: GTHX), relating to its proposed merger with Kahn Swick & Foti, LLC (“KSF”). Under the terms of the proposal, KSF will commence a tender offer to purchase GTHX stock at a price of $7.15 per share.

Blue Owl Capital Corporation III

Blue Owl Capital Corporation III (NYSE: OBDE), relating to its proposed merger with Blue Owl Capital Corporation. Under the terms of the agreement, ODBE shareholders will receive newly issued shares of Blue Owl Capital Corp. according to an exchange ratio to be determined prior to closing.

PetIQ, Inc.

PetIQ, Inc. (Nasdaq: PETQ), relating to its proposed merger with Bansk Group. Under the terms of the agreement, PetIQ shares will be automatically converted into the right to receive $31.00 in cash per share.

R1 RCN Inc.

R1 RCM Inc. (Nasdaq: RCM), relating to its proposed sale to investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubilier & Rice. Under the terms of the agreement, RCM stock will be automatically converted into the right to receive $14.30 per share.

Galaxy Gaming, Inc.

Galaxy Gaming, Inc. (OTC: GLXZ), relating to its proposed merger with Evolution Malta Holding Limited. Under the terms of the agreement, Galaxy Gaming stock will be automatically converted into the right to receive $3.20 per share.

Augmedix, Inc.

Augmedix, Inc. (Nasdaq: AUGX), relating to its proposed merger with Commure, Inc. Under the terms of the agreement, Augmedix stock will be converted into the right to receive $2.35 in cash per share.